Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 2
1970 4
1971 1
1972 1
1974 2
1975 1
1976 4
1977 3
1978 6
1979 6
1980 5
1981 5
1982 4
1983 4
1984 5
1985 4
1986 3
1987 5
1988 4
1989 9
1990 4
1991 10
1992 11
1993 13
1994 13
1995 15
1996 16
1997 11
1998 9
1999 11
2000 6
2001 17
2002 13
2003 14
2004 15
2005 16
2006 17
2007 12
2008 16
2009 10
2010 11
2011 22
2012 17
2013 10
2014 18
2015 13
2016 7
2017 4
2018 15
2019 10
2020 11
2021 8
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

453 results
Results by year
Filters applied: . Clear all
Page 1
Your search for angiotensin II antagoists pregnancy retrieved no results
Pregnancy-Induced hypertension.
Kintiraki E, Papakatsika S, Kotronis G, Goulis DG, Kotsis V. Kintiraki E, et al. Hormones (Athens). 2015 Apr-Jun;14(2):211-23. doi: 10.14310/horm.2002.1582. Hormones (Athens). 2015. PMID: 26158653 Free article. Review.
Pregnancy-induced hypertension (PIH) complicates 6-10% of pregnancies. ...Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II antagonists are contraindicated in pregnancy due to their association with increased
Pregnancy-induced hypertension (PIH) complicates 6-10% of pregnancies. ...Angiotensin-converting enzyme (ACE) inhibi
Clinical pharmacokinetics of losartan.
Sica DA, Gehr TW, Ghosh S. Sica DA, et al. Clin Pharmacokinet. 2005;44(8):797-814. doi: 10.2165/00003088-200544080-00003. Clin Pharmacokinet. 2005. PMID: 16029066 Review.
Losartan should be avoided in pregnancy, as is the case with all other angiotensin-receptor antagonists. ...Losartan is a competitive antagonist that causes a parallel rightward shift of the concentration-contractile response curve to angiotensin
Losartan should be avoided in pregnancy, as is the case with all other angiotensin-receptor antagonists. ...Losartan is …
New approaches in the treatment of hypertension.
Oparil S, Schmieder RE. Oparil S, et al. Circ Res. 2015 Mar 13;116(6):1074-95. doi: 10.1161/CIRCRESAHA.116.303603. Circ Res. 2015. PMID: 25767291 Review.
In this Compendium Review, we discuss new drugs and interventional treatments that are undergoing preclinical or clinical testing for hypertension treatment. New drug classes, eg, inhibitors of vasopeptidases, aldosterone synthase and soluble epoxide hydrolase, agonists of …
In this Compendium Review, we discuss new drugs and interventional treatments that are undergoing preclinical or clinical testing for hypert …
Use of angiotensin II receptor blocker during pregnancy: A case report.
Wei Q, Zhang L, Duan MF, Wang YM, Huang N, Song CR. Wei Q, et al. Medicine (Baltimore). 2021 Jan 22;100(3):e24304. doi: 10.1097/MD.0000000000024304. Medicine (Baltimore). 2021. PMID: 33546057 Free PMC article.
BACKGROUND: Drugs that affect the renin-angiotensin system, such as angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors are not typically recommended for pregnant women because of their potential fetal toxicity. …
BACKGROUND: Drugs that affect the renin-angiotensin system, such as angiotensin II receptor blockers (ARBs) and angi
Angiotensin II receptor antagonist treatment during pregnancy.
Alwan S, Polifka JE, Friedman JM. Alwan S, et al. Birth Defects Res A Clin Mol Teratol. 2005 Feb;73(2):123-30. doi: 10.1002/bdra.20102. Birth Defects Res A Clin Mol Teratol. 2005. PMID: 15669052 Review.
Angiotensin II (A-II) is the main effector of the renin-angiotensin system. ...The fetal abnormalities, which are strikingly similar to those produced by maternal treatment with angiotensin-converting enzyme (ACE) inhibitors during the se
Angiotensin II (A-II) is the main effector of the renin-angiotensin system. ...The fetal abnormalities, which ar
Arterial Tortuosity Syndrome.
Callewaert B, De Paepe A, Coucke P. Callewaert B, et al. 2014 Nov 13 [updated 2022 Jul 14]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. 2014 Nov 13 [updated 2022 Jul 14]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. PMID: 25392904 Free Books & Documents. Review.
Although hemodynamic stress on arterial walls can be reduced with use of beta-adrenergic blockers or other medications including angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor 1 (ATIIR1) antagonists such as losartan …
Although hemodynamic stress on arterial walls can be reduced with use of beta-adrenergic blockers or other medications including angioten
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.
Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Habashi JP, et al. Science. 2006 Apr 7;312(5770):117-21. doi: 10.1126/science.1124287. Science. 2006. PMID: 16601194 Free PMC article.
We show that aortic aneurysm in a mouse model of MFS is associated with increased TGF-beta signaling and can be prevented by TGF-beta antagonists such as TGF-beta-neutralizing antibody or the angiotensin II type 1 receptor (AT1) blocker, losartan. ...
We show that aortic aneurysm in a mouse model of MFS is associated with increased TGF-beta signaling and can be prevented by TGF-beta ant
Angiotensin II receptors and drug discovery in cardiovascular disease.
Dasgupta C, Zhang L. Dasgupta C, et al. Drug Discov Today. 2011 Jan;16(1-2):22-34. doi: 10.1016/j.drudis.2010.11.016. Epub 2010 Dec 13. Drug Discov Today. 2011. PMID: 21147255 Free PMC article. Review.
Hypertension is one of the cardiovascular diseases that might cause cardiovascular remodeling and endothelial dysfunction besides high blood pressure. Angiotensin II (Ang II) receptors are implicated in hypertension. Genetic and epigenetic manipulations of th …
Hypertension is one of the cardiovascular diseases that might cause cardiovascular remodeling and endothelial dysfunction besides high blood …
Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney.
Sánchez SI, Seltzer AM, Fuentes LB, Forneris ML, Ciuffo GM. Sánchez SI, et al. Eur J Pharmacol. 2008 Jun 24;588(1):114-23. doi: 10.1016/j.ejphar.2008.04.014. Epub 2008 Apr 9. Eur J Pharmacol. 2008. PMID: 18495111
Evidence suggests that Angiotensin II plays an important role in the complex process of renal organogenesis. ...The present study demonstrates histologic modifications and changes in receptor localisation in animals born from mothers treated with Angiotensin
Evidence suggests that Angiotensin II plays an important role in the complex process of renal organogenesis. ...The present st …
453 results